Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield. Targeting microbiome is a key.

Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

PARIS and CAMBRIDGE, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based ...

“This collaboration underscores our belief in zanzalintinib’s potential to drive patient benefit in combination with immunotherapy or targeted therapy in HNSCC and RCC indications that have unmet ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain head and neck cancers from returning. Continuous use of Keytruda—both ...

Antibody-drug conjugates (ADCs) are fusions of therapeutic drugs and antibodies conjugated by a linker, designed to deliver a therapeutic payload to cells expressing the target antigen. By delivering ...

To remove head and neck tumours, surgeons must navigate intricate networks of nerves and blood vessels, as well as the brain and spine, says Yao Li, a robotic scientist at Stanford University, in the ...

What Is Tongue Cancer? Symptoms, Causes, Diagnosis, Treatment, and PreventionMedically Reviewed by Walter Tsang, MD | October 11, 2023 What Is Head and Neck Cancer? Causes, Symptoms, Diagnosis, ...

Head and neck cancers represent 4% of U.S. cancer cases, with significant mortality rates, highlighting the need for awareness and early detection. These cancers affect multiple anatomical sites, ...